The Human Side of Biopharma's AI Transformation

AI is reshaping how biopharma companies operate, but the foundation underneath isn't keeping pace. In our 2026 State of Patient-Centricity report, Founder & CEO Danny Sigurdson spoke with commercial leaders from Genentech, Pfizer, AstraZeneca, and more to understand where the gaps are, why they persist, and what separates the companies that are pulling ahead.